| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/10/2011 | US20110033553 Embolization |
| 02/10/2011 | US20110033508 Injectable microspheres for dermal augmentation and tissue bulking |
| 02/10/2011 | US20110033390 Mr imaging agent or medium compressing hyperpolarised 13c alanine and methods of imaging wherein such an imaging medium is used |
| 02/10/2011 | US20110033389 Modified antibodies for passive immunotherapy |
| 02/10/2011 | US20110033388 Imageable rodent model of asthma |
| 02/10/2011 | US20110033387 Method of determination of pdh activity and imaging media for use in said method |
| 02/10/2011 | US20110033386 Method of detecting bladder cancer |
| 02/10/2011 | US20110033385 Methods and apparatus for non-invasive determination of patient's blood conditions |
| 02/10/2011 | US20110033384 Chimeric polypeptides and their use |
| 02/10/2011 | US20110033383 Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptors and adaptors thereof |
| 02/10/2011 | US20110033381 Molecular probe for imaging of pancreatic islet and the precursor, and use of the same |
| 02/10/2011 | CA2769882A1 Targeting of bone marrow neovasculature |
| 02/10/2011 | CA2769001A1 Novel proteins |
| 02/09/2011 | EP2281843A1 Antibodies that immunospecifically bind to blys |
| 02/09/2011 | EP2281842A1 Antibodies that immunospecifically bind to BLyS |
| 02/09/2011 | EP2281580A2 Labeled gastrin releasing peptides (GRP) |
| 02/09/2011 | EP2281066A2 Biomarkers for depression |
| 02/09/2011 | EP2280737A2 Magnetic microstructures for magnetic resonance imaging |
| 02/09/2011 | EP2280736A2 Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications |
| 02/09/2011 | EP2280735A2 Agents for detecting and imaging cell death |
| 02/09/2011 | CN1799631B Animal model for fetal alcohol syndrome and methods of treatment |
| 02/09/2011 | CN101970015A N-alkoxyamide conjugates as imaging agents |
| 02/09/2011 | CN101970014A Imaging medium comprising hyperpolarised 13c-lactate and use thereof |
| 02/09/2011 | CN101966344A Hollow core-shell nanometer mesoporous medicament carrying system with magnetism and luminescent performance, preparation method and application thereof |
| 02/09/2011 | CN101966343A Carbon nanotube/magnetic nanoparticle magnetic resonance contrast medium and preparation method thereof |
| 02/09/2011 | CN101966342A Method for evaluating biological equivalence of medicinal preparations by using early blood concentration-time data |
| 02/09/2011 | CN101966077A Multi-angle imaging device |
| 02/09/2011 | CN101658680B Medical environment-friendly sterilization ultrasound coupling agent and preparation method thereof |
| 02/09/2011 | CN101648024B Medicinal liquid preparation of glucose for OGTT and preparation method thereof |
| 02/09/2011 | CN101178961B Water soluble magnetic nanometer crystal with high dissolvability and method of producing the same |
| 02/08/2011 | US7884197 oligonucleotide-based compounds that individually provide distinct immune response profiles through their interactions as agonists with Toll-like receptors (TLR9) |
| 02/08/2011 | US7884183 Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
| 02/08/2011 | US7884178 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 02/08/2011 | US7884087 Amides of hyaluronic acid the derivatives thereof and a process for their preparation |
| 02/08/2011 | CA2438325C Patch for screening the sensitivity state of a subject with respect to an allergen and use thereof |
| 02/08/2011 | CA2403900C Substituted chalcones as therapeutic compounds |
| 02/03/2011 | WO2011013792A1 Kidney imaging agent comprising genetically modified gelatin |
| 02/03/2011 | WO2011013038A2 Perfluoro compounds for use in imaging |
| 02/03/2011 | WO2011012646A2 Non-invasive in vivo optical imaging method |
| 02/03/2011 | WO2010076237A3 Nanoparticle contrast agents for diagnostic imaging |
| 02/03/2011 | US20110028567 Smooth muscle contraction inhibitors |
| 02/03/2011 | US20110027190 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label |
| 02/03/2011 | US20110027189 Biocompatible products for magnetic particle imaging |
| 02/03/2011 | US20110027188 Methods, Compositions and Devices for Treating Lesioned Sites Using Bioabsorbable Carriers |
| 02/03/2011 | US20110027187 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome |
| 02/03/2011 | US20110027186 Taz/wwtr1 for diagnosis and treatment of cancer |
| 02/03/2011 | US20110027185 Methods of Screening for Anti-Angiogenic Compounds |
| 02/03/2011 | US20110027184 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c-like compound administration |
| 02/03/2011 | US20110027183 Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver |
| 02/03/2011 | US20110027182 Substance for obtaining highly effective tumor medications as well as a process |
| 02/03/2011 | US20110027181 Device including altered microorganisms, and methods and systems of use |
| 02/03/2011 | US20110027180 Detection and treatment of prostate cancer |
| 02/03/2011 | US20110027176 Homing peptide for tumor vasculature |
| 02/03/2011 | US20110027175 Cancer imaging and treatment |
| 02/03/2011 | CA2768330A1 Non-invasive in vivo optical imaging method |
| 02/02/2011 | EP2280052A1 Fluorescent compounds for the diagnosis of infections, production method, and applications thereof |
| 02/02/2011 | EP2280024A2 Polypeptide specifically coupled to phosphatidylserine and use thereof |
| 02/02/2011 | EP2279759A2 Compounds and methods for 18F labeled agents |
| 02/02/2011 | EP2279757A2 Compounds for targeting endothelial cells |
| 02/02/2011 | EP2279010A2 Renal function analysis method and apparatus |
| 02/02/2011 | CN1899615B Preparation for the prophylaxis of restenose |
| 02/02/2011 | CN101961498A Endotoxin removal in contrast media |
| 02/02/2011 | CN101961493A Ace2 activation for treatment of heart, lung and kidney disease and hypertension |
| 02/01/2011 | US7879993 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 02/01/2011 | US7879548 Detection of biomarkers for neuropsychiatric disorders |
| 02/01/2011 | US7879340 blocking, reducing allergic rhinitis via antibodies contacting antigen, by administration of neurotoxin derived from Clostridium; absorbent pledgets, biodegradable carriers; lyophilization; liposomes |
| 02/01/2011 | US7879314 Optical imaging of rheumatoid arthritis |
| 02/01/2011 | CA2453887C Bone cement having improved mechanical properties, and process for the preparation thereof |
| 01/27/2011 | WO2011011384A2 Synthesis of dendrimer conjugates |
| 01/27/2011 | WO2011010848A2 Multifunctional nanoparticles for fluorescence, mr and pet images comprising magnetic silica nanoparticles doped with a near-infrared (nir) dye allowing composite imaging of lymph nodes and deep organs, and a method for synthesising the same |
| 01/27/2011 | WO2011010674A1 Polymer micelle composite for contrasting in mri |
| 01/27/2011 | WO2011010243A1 Apparatus and method for influencing and/or detecting magnetic particles |
| 01/27/2011 | WO2011009539A1 ε-POLYLYSINE CONJUGATES AND USE THEREOF |
| 01/27/2011 | WO2010096426A3 Compounds, compositions, methods of synthesis, and methods of treatment |
| 01/27/2011 | US20110023151 Genome editing of abc transporters |
| 01/27/2011 | US20110023149 Genomic editing of genes involved in tumor suppression in animals |
| 01/27/2011 | US20110023146 Genomic editing of genes involved in secretase-associated disorders |
| 01/27/2011 | US20110023144 Genomic editing of genes involved in amyotrophyic lateral sclerosis disease |
| 01/27/2011 | US20110023141 Genomic editing of genes involved with parkinson's disease |
| 01/27/2011 | US20110023139 Genomic editing of genes involved in cardiovascular disease |
| 01/27/2011 | US20110023137 Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof |
| 01/27/2011 | US20110021908 Methods and systems for spatially identifying abnormal cells |
| 01/27/2011 | US20110020243 Methods and compositions for imaging cancer cells |
| 01/27/2011 | US20110020242 High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles |
| 01/27/2011 | US20110020241 Fluorescent labeling agent containing quantum dots |
| 01/27/2011 | US20110020240 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics |
| 01/27/2011 | US20110020239 Methods for in vivo imaging of cells |
| 01/27/2011 | US20110020238 Stabilizing aqueous solution of iodine chloride by adding sodium chloride |
| 01/27/2011 | US20110020237 Compositions and Methods for Inhibiting Drusen Formation and for Diagnosing or Treating Drusen-Related Disorders |
| 01/27/2011 | US20110020236 Method for the synthesis of hollow spheres |
| 01/27/2011 | US20110020234 Rna interference mediating small rna molecules |
| 01/27/2011 | US20110020233 Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof |
| 01/27/2011 | US20110020232 Cancer treatment with gama-secretase inhibitors |
| 01/27/2011 | US20110020231 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 01/27/2011 | US20110020230 Biomarkers for prostate cancer |
| 01/27/2011 | US20110020229 Multi-Component Biological Transport Systems |
| 01/27/2011 | US20110020228 Targeted cellular selectivity of surface active molecules |
| 01/27/2011 | US20110020227 Polysaccharide-containing block copolmer particles and uses thereof |
| 01/27/2011 | US20110020226 Particle structures comprising sterols and saponins |
| 01/27/2011 | US20110020225 Porous polymer particles immobilized with charged molecules and method for preparing the same |